#EBW25 Previews: 4D: Balancing Ethics and Innovation: ELSI in Biobanking
Biobanking would not be possible without taking into account all the ethical, social and legal implications that are inextricably linked to biobanking activities. In this session, we will present the current state of affairs in ELSI as well as how the impetus for innovation and biomedical knowledge production can be enhanced by implementing an embedded ethics approach.
This session will be chaired by:
Dr. Valentina Colcelli
Dr. Valentina Colcelli is a Senior Researcher at the Italian National Research Council (CNR). Her main research focus is on the interaction of domestic and European law in shaping rights and interests and market regulation. She is also interested in a general reflection on personal and non-personal data beyond the EU legal system, internal market regulation, personal data protection, data circulation, legal and ethical issues in research and innovation activities and Artificial Intelligence, and adequate judicial protection of biodiversity considering fundamental rights.
Valentina has published books on EU integration and has written over 90 papers and books. She is a member of several EU-funded projects and long-lasting international research collaborations such as the H2020 and Horizon Europe. She is also:
- Co-chair of the Working Group “Regulatory, Ethics, and GDPR” for the scientific association “European, Middle Eastern & African Society for Biopreservation and Biobanking” (ESBB) and a member of the ESBB Council.
- Visiting external examiner at the University of Malta and Independent External Ethics Advisor for European Cancer Imaging Initiative (EUCAIM project, funded under the DIGITAL programme).
- Active in Techniques for prostatE cancer (FLUTE) HORIZON-HLTH-2022-IND-13 action under the Horizon Europe Framework with grant agreement Nr.101095382.
- External Ethical Advisor in Optimise and predict antidepressant efficacy for patients with major depressive disorders using multi-omics analysis and AI-predictive tool – OPADE, action under HORIZON-HLTH-2022-TOOL-11-01.
- External Ethical Advisor in HORIZON-HLTH-2024-DISEASE-03-13-two-stage – PREDICTFTD – Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification.
- Member of the ELSI team for the European Platform for Neurodegenerative Diseases (EPND) and of the Ethics Committee of university hospital “Azienda Ospedaliero-Universitaria Meyer” (AOU Meyer).
Prof. Marialuisa Lavitrano
Marialuisa Lavitrano is a full professor of Pathology at Milano-Bicocca University, directing the Molecular Medicine Unit and the Executive Masters in Research Infrastructure Management. She is the BBMRI.it national node director, has contributed to national and international strategies, and is involved in bioethics. In 2020, she was elected vice-president of the EOSC Association.
Session details
- Date: Wednesday 14 May
- Time: 17:30-19:00